Protecting the Ureter during Radiofrequency Ablation of Renal Cell Cancer: A Pilot Study of Retrograde Pyeloperfusion with Cooled Dextrose 5% in Water

• Published in: Journal of vascular and interventional radiology Vol. 19; no. 7; pp. 1034 - 1040
• Main Authors: Cantwell, Colin P., MB, BCh, BAO, MSc, MRCS, FRCR, FFR, Wah, Tze M., MD, Gervais, Debra A., MD, Eisner, Brian H., MD, Arellano, Ronald, MD, Uppot, Raul N., MD, Samir, Anthony E., MD, Irving, Henry C., MD, McGovern, Francis, MD, Mueller, Peter R., MD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2008
• Subjects: Aged; Boston; Carcinoma, Renal Cell - pathology; Carcinoma, Renal Cell - surgery; Catheter Ablation - adverse effects; Cold Temperature; England; Feasibility Studies; Female; Glucose - therapeutic use; Humans; Hydronephrosis - etiology; Hydronephrosis - prevention & control; Kidney Neoplasms - pathology; Kidney Neoplasms - surgery; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Perfusion; Pilot Projects; Radiology; Reoperation; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Diseases - etiology; Ureteral Diseases - prevention & control; Urinary Catheterization; England; Boston; renal cell carcinoma; RCC; RF; dextrose 5% in water; D5W; radiofrequency

Purpose To describe early experience with cooled dextrose 5% in water (D5W) solution retrograde pyeloperfusion during radiofrequency (RF) ablation of renal cell carcinoma (RCC) within 1.5 cm of the ureter with respect to feasibility, safety, and incidence of residual/recurrent tumor in proximity to...